SCHEMBL27636764

SCHEMBL27636764

NS(=O)(=O)c1cccc2ncc3ccccc3c12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.56
CA1 P00915 7/20 0.56
CA9 Q16790 6/20 0.56
KDM4E B2RXH2 2/20 0.50
GPR3 P46089 1/20 0.50
MAPK1 P28482 1/20 0.46
CA12 O43570 4/20 0.43
CDK2 P24941 1/20 0.42
ALOX5AP P20292 2/20 0.42
FEN1 P39748 2/20 0.42
CA4 P22748 2/20 0.39
CA6 P23280 2/20 0.39
CYP2C9 P11712 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
LOXL2 Q9Y4K0 2/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL329916 0.87 KDM4E (0.50) CA2CA1CA9KDM4EGPR3
SCHEMBL9780253 0.86 KDM4E (0.49) CA2CA1CA9KDM4EGPR3
SCHEMBL329917 0.86 KDM4E (0.49) CA2CA1CA9KDM4EGPR3
SCHEMBL30857515 0.79 KDM4E (0.61) KDM4EGPR3MAPK1TP53CYP1A2
Benzene SCHEMBL12471481 0.78 ALDH1A1 (0.51) CA2CA1CA9KDM4EGPR3
SCHEMBL841678 0.76 KDM4E (0.57) KDM4EGPR3CYP2C9TP53CYP1A2
SCHEMBL241588 0.76 KDM4E (0.57) KDM4EGPR3CYP1A2MAPTHPGD
SCHEMBL29598792 0.76 KDM4E (0.57) KDM4EGPR3CYP1A2MAPTHPGD
SCHEMBL329200 0.76 KDM4E (0.57) KDM4EGPR3CYP1A2MAPTHPGD
SCHEMBL329543 0.76 KDM4E (0.57) KDM4EGPR3CYP1A2MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1905864-B DNA damage repair inhibitors for the treatment of cancer KUDOS PHARM LTD 2011-04-06 CN disclosed
CN-1905864-A DNA damage repair inhibitors for the treatment of cancer KUDOS PHARM LTD (GB) 2007-01-31 CN disclosed
CN-1720231-A Substituted dihydrophenanthridinesulfonamides WYETH CORP (US) 2006-01-11 CN disclosed